CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
Condition(s):T-cell LymphomaLast Updated:October 25, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):T-cell LymphomaLast Updated:October 25, 2023Terminated
Condition(s):Newly Diagnosed Peripheral T-cell LymphomaLast Updated:August 4, 2023Recruiting
Condition(s):Cutaneous T Cell Lymphoma; Peripheral T Cell LymphomaLast Updated:August 28, 2023Recruiting
Condition(s):Peripheral T-Cell LymphomaLast Updated:March 7, 2013Completed
Condition(s):Peripheral T-cell LymphomaLast Updated:April 5, 2023Recruiting
Condition(s):Peripheral T-cell LymphomaLast Updated:May 12, 2020Unknown status
Condition(s):T-cell LymphomaLast Updated:March 12, 2024Recruiting
Condition(s):Previously Untreated Peripheral T-cell LymphomaLast Updated:August 22, 2023Completed
Condition(s):Peripheral T-Cell LymphomaLast Updated:July 9, 2020Recruiting
Condition(s):Peripheral T-cell LymphomaLast Updated:February 11, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.